131 related articles for article (PubMed ID: 996993)
1. [Antineoplastic drugs: resistance and metabolism].
Lavigne JG
Union Med Can; 1976 Feb; 105(2):186-8. PubMed ID: 996993
[No Abstract] [Full Text] [Related]
2. [Resistance, the cause of failure in antineoplastic chemotherapies].
Israel L
Pathol Biol (Paris); 1989 Feb; 37(2):125-7. PubMed ID: 2652060
[No Abstract] [Full Text] [Related]
3. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
4. [Resistance and resistances].
Cappelaere P
Bull Cancer; 1994 Dec; 81 Suppl 2():115s-117s. PubMed ID: 7727857
[TBL] [Abstract][Full Text] [Related]
5. [Tumor pH-dependent toxicity of antineoplastic agents].
Ardenne M; Reitnauer PG
Pharmazie; 1977 Feb; 32(2):74-5. PubMed ID: 16278
[No Abstract] [Full Text] [Related]
6. [New drugs in early clinical trials and drug resistance--US-Japan joint seminar].
Ogawa M
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):697-700. PubMed ID: 2321989
[No Abstract] [Full Text] [Related]
7. [Resistance testing of malignant tumors. Possibility of analysis of the clinical development of secondary resistance to cytostatic drugs].
Possinger K; Hartenstein R; Ehrhart H
MMW Munch Med Wochenschr; 1978 May; 120(21):725-8. PubMed ID: 306551
[No Abstract] [Full Text] [Related]
8. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
Hofsli E
Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive agents in systemic chemotherapy.
Lyman GH
Compr Ther; 1980 Oct; 6(10):16-25. PubMed ID: 6778649
[No Abstract] [Full Text] [Related]
10. Drug resistance in cancer therapy.
Cancer Treat Res; 1989; 48():1-203. PubMed ID: 2577132
[No Abstract] [Full Text] [Related]
11. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
[TBL] [Abstract][Full Text] [Related]
12. Safer cancer chemotherapy using a kinetically based experimental approach.
Price LA; Hill BT
Mt Sinai J Med; 1985 Jun; 52(6):452-9. PubMed ID: 3875025
[No Abstract] [Full Text] [Related]
13. [Pretherapeutical testing of antineoplastic drugs in vitro (author's transl)].
Projan A; Tanneberger S; Peek U; Nissen E
Arch Geschwulstforsch; 1982; 52(1):1-7. PubMed ID: 7082128
[TBL] [Abstract][Full Text] [Related]
14. First Annual Pezcoller Symposium. Drug resistance--mechanisms and reversal.
Mihich E
Cancer Res; 1989 Dec; 49(24 Pt 1):7168-71. PubMed ID: 2582457
[No Abstract] [Full Text] [Related]
15. New test reveals extreme drug resistance in many cancer patients.
Oncology (Williston Park); 1990 May; 4(5):76. PubMed ID: 2143412
[No Abstract] [Full Text] [Related]
16. [Multidrug resistance].
Donenko FV; Sitdikova SM; Moroz LV
Vopr Onkol; 1991; 37(7-8):780-8. PubMed ID: 1842629
[No Abstract] [Full Text] [Related]
17. Intrinsic versus acquired drug resistance.
Mackillop WJ
Cancer Treat Rep; 1986 Jun; 70(6):817-8. PubMed ID: 3731144
[No Abstract] [Full Text] [Related]
18. Overcoming drug resistance in the treatment of cancer.
Am Pharm; 1984 Apr; NS24(4):12-4. PubMed ID: 6720567
[No Abstract] [Full Text] [Related]
19. [Use of cytostatic drugs in therapy and research].
Wie H
Tidsskr Nor Laegeforen; 1973 Mar; 93(7):443-9. PubMed ID: 4699142
[No Abstract] [Full Text] [Related]
20. [Membrane transport of antineoplastic drugs and its relevance to tumour chemotherapy (author's transl)].
Kolassa N
Wien Klin Wochenschr; 1980; 92(20):707-15. PubMed ID: 7467345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
